Raymond Michael Shaheen, MD
Vascular Surgery · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 6 carriers
- Office
- 1
Offices
1 location
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
21 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shaheen’s office at (650) 965-1909 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A63071 · Current
Licensed to practise in California · since 1997 · expires 2028-11-30 · University of Louisville School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$589,998
Medicare paid this office $589,998 for 278 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Epifix, per square centimeter | 19 | $133,260 | $120 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 42 | $121,256 | $2,091 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 168 | $48,512 | $189 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 23 | $42,425 | $1,632 |
| Return visit (30+ min) | 142 | $29,847 | $114 |
See all 21 services
| Epifix, per square centimeter | 19 | $133,260 | $120 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 42 | $121,256 | $2,091 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 168 | $48,512 | $189 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 23 | $42,425 | $1,632 |
| Return visit (30+ min) | 142 | $29,847 | $114 |
| Long return visit (40+ min) | 90 | $26,935 | $164 |
| Telephone medical discussion with physician, 21-30 minutes | 83 | $15,102 | $120 |
| Short return visit (20+ min) | 87 | $14,621 | $85 |
| Ultrasound of both sides of head and neck blood flow | 50 | $11,060 | $201 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 47 | $10,333 | $124 |
| Strapping, unna boot | 28 | $10,041 | $74 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 18 | $9,505 | $151 |
| New patient visit (60+ min) | 42 | $8,474 | $202 |
| Injection of chemical agent into multiple incompetent veins of leg | 32 | $6,600 | $157 |
| New patient visit (45+ min) | 40 | $5,700 | $142 |
| Ultrasound of leg arteries or artery grafts | 19 | $4,902 | $245 |
| Coronary artery bypass using artery graft, 1 graft | 18 | $4,201 | $233 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 18 | $3,557 | $178 |
| Removal of tissue from wound, 20.0 sq cm or less | 12 | $3,137 | $101 |
| Ultrasonic guidance for needle placement | 20 | $1,385 | $55 |
| Short return visit | 14 | $1,000 | $48 |
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 16 | More than 58% of doctors who do this |
| Removal of nail tissue | 1-10 | None |
| Removal of tissue | 176 | More than 90% of doctors who do this |
| Varicose vein removal | 166 | More than 89% of doctors who do this |
Who their Medicare patients are
278 Original Medicare patients in 2024. Average age 77 · Women 53% · Also on Medicaid 9% · Health risk score 1.27. At or below the middle of the specialty; the typical vascular surgery clinician is at 2.33.
Conditions among them: High blood pressure 75% · Coronary heart disease 31% · Atrial fibrillation 29% · Diabetes 27% · Chronic kidney disease 24% · Heart failure 20% · Cancer 16% · Depression 14% · COPD 13% · Stroke 10% · Dementia 5%.
The office billed $1,598,344, Medicare allowed $751,190 and paid $589,998; for 3,285 services of 90 kinds; $170,299 of it was for drugs given in the office and $419,699 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 278 | 3,285 | 77 | 1.27 | $1,598,344 | $589,998 |
| 2023 | 230 | 3,036 | 77 | 1.29 | $1,445,380 | $500,798 |
| 2022 | 222 | 2,587 | 77 | 1.39 | $1,490,067 | $558,282 |
| 2021 | 192 | 4,257 | 78 | 1.45 | $1,287,032 | $586,468 |
| 2020 | 130 | 14,858 | 77 | 1.74 | $3,738,271 | $1,911,785 |
| 2019 | 167 | 12,587 | 77 | 1.50 | $3,770,400 | $1,650,941 |
| 2018 | 153 | 11,945 | 77 | 1.68 | $3,720,461 | $1,414,271 |
| 2017 | 157 | 11,376 | 78 | 2.14 | $4,502,097 | $1,572,970 |
| 2016 | 167 | 5,370 | 79 | 2.19 | $2,496,671 | $888,155 |
| 2015 | 166 | 1,737 | 77 | 1.78 | $1,136,911 | $399,005 |
| 2014 | 174 | 1,764 | 76 | 1.51 | $1,559,761 | $504,567 |
| 2013 | 122 | 2,508 | 75 | 1.57 | $1,359,940 | $522,922 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Epifix, per square centimeter | 17 | $107,394 | $119 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 28 | $59,350 | $1,746 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 129 | $38,804 | $194 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 16 | $37,957 | $2,109 |
| Return visit (30+ min) | 130 | $33,208 | $116 |
| Long return visit (40+ min) | 78 | $23,430 | $154 |
| Short return visit (20+ min) | 119 | $17,059 | $81 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 19 | $10,759 | $147 |
| Ultrasound of both sides of head and neck blood flow | 48 | $9,762 | $188 |
| Strapping, unna boot | 27 | $9,452 | $73 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 43 | $8,895 | $125 |
| Ultrasound of leg arteries or artery grafts | 22 | $6,228 | $249 |
| New patient visit (45+ min) | 35 | $5,373 | $154 |
| Injection of chemical agent into multiple incompetent veins of leg | 19 | $4,783 | $184 |
| Coronary artery bypass using artery graft, 1 graft | 13 | $3,137 | $241 |
| New patient visit (60+ min) | 17 | $3,121 | $184 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 12 | $2,307 | $192 |
| Short return visit | 17 | $1,333 | $53 |
| Ultrasonic guidance for needle placement | 15 | $1,228 | $56 |
2022: 19 services
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 43 | $129,127 | $2,391 |
| Epifix, per square centimeter | 13 | $72,203 | $123 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 26 | $50,948 | $1,820 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 132 | $47,221 | $202 |
| Return visit (30+ min) | 127 | $38,661 | $119 |
| Long return visit (40+ min) | 106 | $33,160 | $168 |
| Short return visit (20+ min) | 107 | $22,565 | $85 |
| Strapping, unna boot | 24 | $11,345 | $87 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 55 | $11,205 | $127 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 13 | $10,328 | $156 |
| Ultrasound of both sides of head and neck blood flow | 46 | $10,161 | $207 |
| Ultrasound of leg arteries or artery grafts | 21 | $7,713 | $266 |
| Removal of tissue from wound, 20.0 sq cm or less | 15 | $7,244 | $107 |
| Injection of chemical agent into multiple incompetent veins of leg | 23 | $6,277 | $174 |
| New patient visit (45+ min) | 30 | $4,397 | $147 |
| New patient visit (60+ min) | 21 | $4,141 | $197 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 16 | $3,129 | $196 |
| Coronary artery bypass using artery graft, 1 graft | 11 | $2,819 | $256 |
| Ultrasonic guidance for needle placement | 19 | $1,670 | $58 |
2021: 18 services
| Epifix, per square centimeter | 14 | $201,676 | $124 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 35 | $116,770 | $2,484 |
| Short return visit (20+ min) | 121 | $36,768 | $87 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 106 | $33,597 | $209 |
| Return visit (30+ min) | 81 | $18,070 | $124 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 15 | $12,931 | $156 |
| Strapping, unna boot | 17 | $9,922 | $86 |
| Removal of tissue from wound, 20.0 sq cm or less | 27 | $9,840 | $105 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 49 | $9,707 | $128 |
| Long return visit (40+ min) | 38 | $9,288 | $169 |
| Ultrasound of both sides of head and neck blood flow | 27 | $6,806 | $213 |
| Ultrasound of leg arteries or artery grafts | 14 | $6,133 | $279 |
| New patient visit (45+ min) | 36 | $5,568 | $155 |
| Injection of chemical agent into multiple incompetent veins of leg | 17 | $3,989 | $199 |
| New patient visit (60+ min) | 17 | $3,558 | $209 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 13 | $3,234 | $190 |
| New patient visit (30+ min) | 25 | $2,517 | $101 |
| Short return visit | 23 | $2,008 | $54 |
2020: 13 services
| Epifix, per square centimeter | 18 | $1,475,462 | $128 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 27 | $91,086 | $2,462 |
| Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | 15 | $42,715 | $2,248 |
| Long return visit (40+ min) | 91 | $37,057 | $134 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 18 | $30,448 | $224 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 73 | $22,998 | $195 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 16 | $11,042 | $99 |
| Short return visit (20+ min) | 34 | $8,010 | $73 |
| Application of skin substitute graft to wound of trunk, arms, or legs, each additional 25.0 sq cm of wound 100.0 sq cm or less | 11 | $5,339 | $25 |
| New patient visit (60+ min) | 23 | $4,442 | $193 |
| Ultrasound of leg arteries or artery grafts | 13 | $3,899 | $260 |
| Ultrasound of both sides of head and neck blood flow | 12 | $2,850 | $204 |
| Short return visit | 19 | $1,981 | $45 |
2019: 16 services
| Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter | 22 | $530,716 | $107 |
| Epifix, per square centimeter | 23 | $489,680 | $126 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 58 | $291,545 | $2,675 |
| Long return visit (40+ min) | 134 | $64,700 | $133 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 114 | $56,824 | $195 |
| Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | 21 | $52,151 | $2,006 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 28 | $43,102 | $218 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 22 | $15,356 | $86 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 16 | $12,019 | $67 |
| New patient visit (60+ min) | 58 | $10,629 | $183 |
| Short return visit (20+ min) | 26 | $7,471 | $70 |
| Ultrasound of leg arteries or artery grafts | 15 | $5,864 | $267 |
| Application of skin substitute graft to wound of trunk, arms, or legs, each additional 25.0 sq cm of wound 100.0 sq cm or less | 13 | $4,378 | $25 |
| Injection of chemical agent into multiple incompetent veins of leg | 14 | $3,912 | $170 |
| Short return visit | 31 | $3,194 | $44 |
| Chemical destruction of subsequent incompetent veins of arm or leg using imaging guidance | 14 | $2,241 | $140 |
2018: 18 services
| Epifix or epicord, per square centimeter | 25 | $687,286 | $127 |
| Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | 31 | $93,287 | $1,904 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 24 | $62,522 | $1,690 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 16 | $61,388 | $2,361 |
| Long return visit (40+ min) | 113 | $59,587 | $127 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 23 | $47,080 | $204 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 88 | $43,621 | $190 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 17 | $13,559 | $63 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 21 | $11,149 | $68 |
| New patient visit (60+ min) | 44 | $7,771 | $177 |
| Short return visit (20+ min) | 20 | $7,510 | $65 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 14 | $5,767 | $262 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,424 | $171 |
| Injection of chemical agent into multiple incompetent veins of leg | 12 | $3,143 | $150 |
| Short return visit | 45 | $2,963 | $40 |
| Ultrasound of both sides of head and neck blood flow | 12 | $2,670 | $191 |
| Chemical destruction of subsequent incompetent veins of arm or leg using imaging guidance | 12 | $2,257 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,026 | $88 |
2017: 20 services
| Epifix or epicord, per square centimeter | 33 | $1,088,202 | $127 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 39 | $163,222 | $1,755 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 32 | $77,271 | $206 |
| Long return visit (40+ min) | 118 | $56,492 | $128 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 80 | $28,899 | $190 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 25 | $20,246 | $69 |
| Short return visit (20+ min) | 31 | $15,676 | $66 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 15 | $12,219 | $64 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 24 | $9,828 | $266 |
| New patient visit (60+ min) | 47 | $8,525 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $6,016 | $90 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 13 | $5,879 | $74 |
| Ultrasound of leg arteries or artery grafts | 13 | $5,456 | $260 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 11 | $4,966 | $134 |
| Return visit (30+ min) | 17 | $3,921 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,134 | $174 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 14 | $2,777 | $107 |
| Removal of skin and tissue, 20.0 sq cm or less | 12 | $2,691 | $84 |
| Short return visit | 17 | $1,092 | $40 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $461 | $18 |
2016: 17 services
| Epifix or epicord, per square centimeter | 20 | $430,526 | $135 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 49 | $172,371 | $1,567 |
| Long return visit (40+ min) | 114 | $64,827 | $124 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 27 | $62,703 | $204 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 84 | $29,629 | $175 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 26 | $12,372 | $269 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 19 | $11,155 | $67 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 42 | $9,421 | $115 |
| Return visit (30+ min) | 50 | $9,225 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $8,483 | $173 |
| New patient visit (60+ min) | 41 | $6,891 | $168 |
| Short return visit (20+ min) | 33 | $6,665 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $6,373 | $89 |
| Ultrasound of leg arteries or artery grafts | 18 | $4,935 | $190 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 11 | $3,081 | $64 |
| Ultrasound of both sides of head and neck blood flow | 11 | $2,989 | $187 |
| Injection of chemical agent into multiple incompetent veins of leg | 23 | $2,582 | $96 |
2015: 16 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 47 | $197,110 | $1,729 |
| Long return visit (40+ min) | 106 | $44,774 | $128 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 91 | $33,544 | $184 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 20 | $13,770 | $206 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 31 | $13,496 | $281 |
| Return visit (30+ min) | 63 | $13,097 | $96 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 47 | $12,758 | $115 |
| New patient visit (60+ min) | 48 | $8,361 | $174 |
| Short return visit (20+ min) | 48 | $6,948 | $65 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $5,091 | $102 |
| Ultrasound of leg arteries or artery grafts | 13 | $3,706 | $218 |
| Injection of chemical agent into multiple incompetent veins of leg | 23 | $3,437 | $107 |
| Ultrasound of both sides of head and neck blood flow | 15 | $3,100 | $194 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,824 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,524 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,212 | $64 |
2014: 14 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 57 | $295,413 | $1,931 |
| Long return visit (40+ min) | 83 | $28,853 | $129 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 80 | $23,051 | $183 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 31 | $20,547 | $367 |
| Return visit (30+ min) | 86 | $15,010 | $97 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 52 | $14,821 | $112 |
| Short return visit (20+ min) | 51 | $8,165 | $68 |
| New patient visit (60+ min) | 43 | $7,293 | $170 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $5,535 | $99 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 11 | $4,625 | $210 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 13 | $4,267 | $251 |
| Ultrasound of leg arteries or artery grafts | 12 | $3,611 | $226 |
| Injection of chemical agent into multiple incompetent veins of leg | 12 | $1,807 | $120 |
| Short return visit | 16 | $700 | $41 |
2013: 13 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 51 | $316,444 | $1,884 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 36 | $30,025 | $380 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 69 | $24,558 | $182 |
| Long return visit (40+ min) | 62 | $24,396 | $130 |
| Return visit (30+ min) | 65 | $19,228 | $97 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 50 | $18,168 | $116 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $7,823 | $104 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 25 | $6,719 | $47 |
| Short return visit (20+ min) | 43 | $6,706 | $68 |
| New patient visit (60+ min) | 35 | $6,331 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,783 | $90 |
| New patient visit (45+ min) | 11 | $1,529 | $139 |
| Short return visit | 22 | $1,425 | $42 |
Drugs they prescribed that Part D paid
$27,386
Pharmacies billed $27,386 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (11 of 301) in 2024. At or below the middle of the specialty; the typical vascular surgery clinician is at 11%.
276 generic and 25 brand-name prescriptions · $27,386 in drug cost · 27 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 13 | $9,341 | $719 |
| Pentoxifylline | 68 | $2,388 | $35 |
| Cilostazol | 72 | $871 | $12 |
| Doxycycline Hyclate | 14 | $538 | $38 |
| Gabapentin | 19 | $164 | $9 |
See all 8 drugs
| Xarelto | 13 | $9,341 | $719 |
| Pentoxifylline | 68 | $2,388 | $35 |
| Cilostazol | 72 | $871 | $12 |
| Doxycycline Hyclate | 14 | $538 | $38 |
| Gabapentin | 19 | $164 | $9 |
| Hydrocodone-Acetaminophen | 11 | $66 | $6 |
| Atorvastatin | 19 | $66 | $3 |
| Clopidogrel | 22 | $54 | $2 |
Year by year
| 2024 | 301 | 69 | 4% (11) | 8% | $27,386 |
| 2023 | 239 | 64 | 7% (17) | 11% | $31,369 |
| 2022 | 247 | 46 | 13% (31) | 19% | $34,513 |
| 2021 | 233 | 55 | 15% (35) | 12% | $22,619 |
| 2020 | 416 | 56 | 34% (141) | 11% | $30,442 |
| 2019 | 228 | 50 | 22% (50) | 18% | $20,108 |
| 2018 | 172 | 41 | 31% (53) | 8% | $7,144 |
| 2017 | 156 | 39 | 35% (55) | 8% | $10,932 |
| 2016 | 267 | 47 | 33% (89) | 5% | $24,239 |
| 2015 | 304 | 68 | 27% (81) | None | $17,131 |
| 2014 | 297 | 64 | 31% (93) | 11% | $26,048 |
| 2013 | 261 | 47 | 42% (109) | None | $7,937 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Xarelto | 12 | $10,902 | $909 |
| Pentoxifylline | 30 | $1,307 | $44 |
| Cilostazol | 67 | $1,141 | $17 |
| Atorvastatin | 25 | $509 | $20 |
| Hydrocodone-Acetaminophen | 17 | $146 | $9 |
| Clopidogrel | 11 | $143 | $13 |
2022: 7 drugs
| Xarelto | 26 | $14,414 | $554 |
| Santyl | 14 | $4,098 | $293 |
| Cilostazol | 45 | $1,304 | $29 |
| Atorvastatin | 15 | $495 | $33 |
| Hydrocodone-Acetaminophen | 31 | $366 | $12 |
| Pentoxifylline | 16 | $289 | $18 |
| Clopidogrel | 11 | $117 | $11 |
2021: 6 drugs
| Xarelto | 20 | $11,905 | $595 |
| Cilostazol | 47 | $1,470 | $31 |
| Atorvastatin | 20 | $916 | $46 |
| Hydrocodone-Acetaminophen | 33 | $657 | $20 |
| Ibuprofen | 14 | $71 | $5 |
| Simvastatin | 13 | $44 | $3 |
2020: 9 drugs
| Xarelto | 19 | $12,170 | $641 |
| Eliquis | 14 | $9,312 | $665 |
| Hydrocodone-Acetaminophen | 141 | $1,746 | $12 |
| Cilostazol | 42 | $1,290 | $31 |
| Atorvastatin | 20 | $539 | $27 |
| Amoxicillin-Clavulanate Potass | 19 | $442 | $23 |
| Pentoxifylline | 15 | $390 | $26 |
| Sulfamethoxazole-Trimethoprim | 19 | $147 | $8 |
| Ibuprofen | 19 | $125 | $7 |
2019: 5 drugs
| Eliquis | 18 | $9,692 | $538 |
| Cilostazol | 27 | $611 | $23 |
| Hydrocodone-Acetaminophen | 49 | $507 | $10 |
| Sulfamethoxazole-Trimethoprim | 12 | $225 | $19 |
| Atorvastatin | 16 | $126 | $8 |
2018: 7 drugs
| Hydrocodone-Acetaminophen | 52 | $745 | $14 |
| Ciprofloxacin | 19 | $324 | $17 |
| Sulfamethoxazole-Trimethoprim | 11 | $303 | $28 |
| Cilostazol | 16 | $228 | $14 |
| Amoxicillin-Clavulanate Potass | 11 | $184 | $17 |
| Atorvastatin | 14 | $133 | $10 |
| Diazepam | 12 | $43 | $4 |
2017: 3 drugs
| Amoxicillin-Clavulanate Potass | 17 | $643 | $38 |
| Hydrocodone-Acetaminophen | 53 | $428 | $8 |
| Cilostazol | 11 | $242 | $22 |
2016: 7 drugs
| Hydrocodone-Acetaminophen | 87 | $1,800 | $21 |
| Cilostazol | 29 | $880 | $30 |
| Amoxicillin-Clavulanate Potass | 20 | $703 | $35 |
| Clopidogrel | 18 | $288 | $16 |
| Ciprofloxacin | 15 | $259 | $17 |
| Atorvastatin | 16 | $155 | $10 |
| Diazepam | 14 | $39 | $3 |
2015: 9 drugs
| Doxycycline Hyclate | 18 | $1,371 | $76 |
| Hydrocodone-Acetaminophen | 71 | $1,207 | $17 |
| Doxycycline Monohydrate | 13 | $730 | $56 |
| Cilostazol | 23 | $598 | $26 |
| Clopidogrel | 28 | $319 | $11 |
| Ciprofloxacin | 23 | $187 | $8 |
| Pentoxifylline | 12 | $175 | $15 |
| Sulfamethoxazole-Trimethoprim | 12 | $80 | $7 |
| Diazepam | 28 | $68 | $2 |
2014: 8 drugs
| Hydrocodone-Acetaminophen | 87 | $1,542 | $18 |
| Doxycycline Hyclate | 11 | $822 | $75 |
| Cilostazol | 21 | $492 | $23 |
| Clopidogrel | 19 | $399 | $21 |
| Sulfamethoxazole-Trimethoprim | 24 | $224 | $9 |
| Ciprofloxacin | 13 | $158 | $12 |
| Diazepam | 38 | $81 | $2 |
| Furosemide | 12 | $55 | $5 |
2013: 6 drugs
| Hydrocodone-Acetaminophen | 108 | $1,131 | $10 |
| Cilostazol | 27 | $757 | $28 |
| Clopidogrel | 15 | $360 | $24 |
| Pentoxifylline | 11 | $246 | $22 |
| Sulfamethoxazole-Trimethoprim | 13 | $127 | $10 |
| Diazepam | 24 | $53 | $2 |
Money from drug and device companies
$380 in 2025
| 2025 | 6 | 16 | None | $380 |
| 2024 | 8 | 16 | None | $436 |
| 2023 | 5 | 18 | None | $1,380 |
| 2022 | 7 | 10 | None | $207 |
| 2021 | 5 | 11 | None | $390 |
| 2020 | 6 | 16 | None | $369 |
| 2019 | 9 | 34 | $3,500 | $10,502 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Stravix | $189 | 8 payments
|
| MIMEDX Group | None | $105 | 4 payments
|
| Molnlycke Health Care US | Mepilex Border Flex | $25 | 1 payment
|
| Stryker | Artix Mt | $24 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $21 | 1 payment
|
| Urgo Medical North America | Urgoclean Ag | $16 | 1 payment
|
See all 16 published payments
| Smith+Nephew | Meals · 2025-12-10 | Collagenase Santyl | $21 |
| Stryker | Meals · 2025-12-04 | Artix Mt | $24 |
| Smith+Nephew | Meals · 2025-11-11 | Collagenase Santyl | $10 |
| Smith+Nephew | Meals · 2025-09-10 | Stravix | $43 |
| Smith+Nephew | Meals · 2025-09-08 | Grafix | $6 |
| MIMEDX Group | Meals · 2025-06-21 | None | $14 |
| MIMEDX Group | Meals · 2025-05-24 | None | $34 |
| Smith+Nephew | Meals · 2025-05-22 | Grafix | $19 |
| Molnlycke Health Care US | Meals · 2025-05-06 | Mepilex Border Flex | $25 |
| Urgo Medical North America | Meals · 2025-04-24 | Urgoclean Ag | $16 |
| Smith+Nephew | Meals · 2025-04-23 | Grafix | $39 |
| MIMEDX Group | Meals · 2025-03-26 | None | $19 |
| Smith+Nephew | Meals · 2025-03-18 | Collagenase Santyl | $27 |
| Tactile Systems Technology | Meals · 2025-03-04 | Flexitouch Plus | $21 |
| Smith+Nephew | Meals · 2025-02-26 | Stravix | $23 |
| MIMEDX Group | Meals · 2025-01-18 | None | $39 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $436
| Smith+Nephew | Collagenase Santyl | $117 | 5 payments
|
| Organogenesis | None | $87 | 4 payments
|
| Medtronic | Heli-Fx Endoanchor System | $67 | 1 payment
|
| MIMEDX Group | None | $58 | 2 payments
|
| Biotissue Holdings | None | $36 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $29 | 1 payment
|
| Teleflex | Quikclot | $23 | 1 payment
|
| Urgo Medical North America | Urgok2 | $19 | 1 payment
|
2023: $1,380
| Medtronic | Turbohawk | $1,256 | 12 payments
|
| Tactile Systems Technology | Flexitouch Plus | $48 | 2 payments
|
| Biotissue Holdings | Neox | $41 | 2 payments
|
| Smith+Nephew | Grafix | $19 | 1 payment
|
| Organogenesis | Puraply | $16 | 1 payment
|
2022: $207
| Smith+Nephew | Grafix Pl | $90 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $26 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $23 | 1 payment
|
| Amgen | Repatha | $21 | 1 payment
|
| Boston Scientific | Varithena Administration Pack | $17 | 1 payment
|
| Organogenesis | Puraply | $15 | 1 payment
|
| Nabriva Therapeutics plc | Sivextro | $15 | 1 payment
|
2021: $390
| Janssen Pharmaceuticals | Xarelto | $190 | 5 payments
|
| Organogenesis | Puraply | $101 | 2 payments
|
| Smith+Nephew | Grafix Pl | $51 | 2 payments
|
| Nabriva Therapeutics plc | Sivextro | $25 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $23 | 1 payment
|
2020: $369
| Janssen Pharmaceuticals | Xarelto | $145 | 6 payments
|
| Organogenesis | Puraply | $84 | 4 payments
|
| Musculoskeletal Transplant Foundation | None | $71 | 2 payments
|
| Smith+Nephew | Grafix Pl | $35 | 2 payments
|
| Merz North America | None | $20 | 1 payment
|
| AngioDynamics | Evlt | $13 | 1 payment
|
2019: $10,502
| AngioDynamics | Evlt | $4,813 | 2 payments
|
| Smith+Nephew | Stravix | $3,773 | 13 payments
|
| Osiris Therapeutics | Grafix Pl Prime | $1,176 | 6 payments
|
| Janssen Pharmaceuticals | Xarelto | $311 | 5 payments
|
| PolarityTE | Skinte | $168 | 1 payment
|
| Medtronic Vascular | In.Pact Admiral | $127 | 1 payment
|
| Merz North America | Xeomin | $57 | 3 payments
|
| Pfizer | Eliquis | $54 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1114997434
- Licence
- CA A63071California A63071: Current · expires 2028-11-30
- Trained
- University of Louisville School of Medicine, 1996
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2086S0129X (2086S0129X)
- Mailing address
- 305 South Dr, Suite 7, Mountain View, CA, 94040
- NPI first listed
- 2006-01-26
- NPI last updated
- 2012-12-14
This is when the NPI record was last certified, not a medical board exam.